FI924856A0 - Komplexsalter av hematoporfyrin och dess derivat, samt deras syntes - Google Patents

Komplexsalter av hematoporfyrin och dess derivat, samt deras syntes

Info

Publication number
FI924856A0
FI924856A0 FI924856A FI924856A FI924856A0 FI 924856 A0 FI924856 A0 FI 924856A0 FI 924856 A FI924856 A FI 924856A FI 924856 A FI924856 A FI 924856A FI 924856 A0 FI924856 A0 FI 924856A0
Authority
FI
Finland
Prior art keywords
carboxy
ethylamino
propylamino
group
butylamino
Prior art date
Application number
FI924856A
Other languages
English (en)
Other versions
FI924856A (fi
FI100243B (fi
Inventor
Alfreda Graczyk
Jerzy Konarski
Original Assignee
Wojskowa Akad Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wojskowa Akad Tech filed Critical Wojskowa Akad Tech
Publication of FI924856A0 publication Critical patent/FI924856A0/fi
Publication of FI924856A publication Critical patent/FI924856A/fi
Application granted granted Critical
Publication of FI100243B publication Critical patent/FI100243B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI924856A 1991-10-29 1992-10-26 Menetelmä hematoporfyriinin ja sen johdannaisten kompleksisuolojen val mistamiseksi FI100243B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL29222091 1991-10-29
PL91292220A PL165249B1 (pl) 1991-10-29 1991-10-29 Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL

Publications (3)

Publication Number Publication Date
FI924856A0 true FI924856A0 (fi) 1992-10-26
FI924856A FI924856A (fi) 1993-04-30
FI100243B FI100243B (fi) 1997-10-31

Family

ID=20055985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924856A FI100243B (fi) 1991-10-29 1992-10-26 Menetelmä hematoporfyriinin ja sen johdannaisten kompleksisuolojen val mistamiseksi

Country Status (18)

Country Link
US (1) US5451599A (fi)
EP (1) EP0539960B1 (fi)
JP (1) JP3020759B2 (fi)
CN (1) CN1040328C (fi)
BG (1) BG61648B1 (fi)
CA (1) CA2081605C (fi)
CZ (1) CZ281694B6 (fi)
DE (1) DE69217819T2 (fi)
DK (1) DK0539960T3 (fi)
FI (1) FI100243B (fi)
HR (1) HRP921337B1 (fi)
LV (1) LV11952B (fi)
NO (1) NO300499B1 (fi)
PL (1) PL165249B1 (fi)
RU (1) RU2122003C1 (fi)
SI (1) SI9200286B (fi)
UA (1) UA40568C2 (fi)
YU (1) YU48961B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
CN100558903C (zh) 2000-11-29 2009-11-11 Pci生物技术联合股份有限公司 将分子输递进胞质溶胶的光化学内化法
AU2210402A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for virus-mediated molecule delivery into the cyosol
CN104130266A (zh) * 2013-05-02 2014-11-05 中国医学科学院生物医学工程研究所 一种新型原卟啉衍生物及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (fr) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Dichlorhydrate d'hématoporphyrinate de procaine.
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
CN102565846B (zh) * 2011-12-30 2014-05-14 清华大学 蜂窝型热中子探测器

Also Published As

Publication number Publication date
CA2081605A1 (en) 1993-04-30
LV11952B (en) 1998-06-20
BG97030A (bg) 1994-03-24
DE69217819D1 (de) 1997-04-10
YU94592A (sh) 1995-12-04
YU48961B (sh) 2003-01-31
DE69217819T2 (de) 1997-09-04
SI9200286A (en) 1993-06-30
LV11952A (lv) 1998-01-20
CA2081605C (en) 2002-02-26
US5451599A (en) 1995-09-19
NO300499B1 (no) 1997-06-09
BG61648B1 (bg) 1998-02-27
HRP921337A2 (en) 1994-10-31
JPH05262775A (ja) 1993-10-12
FI924856A (fi) 1993-04-30
HRP921337B1 (en) 2000-02-29
JP3020759B2 (ja) 2000-03-15
EP0539960A3 (en) 1993-06-16
NO924151D0 (no) 1992-10-28
PL292220A1 (en) 1993-09-20
DK0539960T3 (da) 1997-09-15
SI9200286B (en) 2001-06-30
FI100243B (fi) 1997-10-31
CN1071914A (zh) 1993-05-12
EP0539960A2 (en) 1993-05-05
UA40568C2 (uk) 2001-08-15
CN1040328C (zh) 1998-10-21
CZ281694B6 (cs) 1996-12-11
NO924151L (no) 1993-04-30
EP0539960B1 (en) 1997-03-05
CZ325292A3 (en) 1993-09-15
RU2122003C1 (ru) 1998-11-20
PL165249B1 (pl) 1994-11-30

Similar Documents

Publication Publication Date Title
ATE31718T1 (de) Mevalolacton-analoga und derivate, verfahren zur herstellung, pharmazeutische zusammenstellungen die sie enthalten und ihre verwendung als arzneimittel.
ATE130604T1 (de) Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE122004000034I2 (de) Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür
DK0835888T3 (da) En ikke-tværbundet anionbytterharpiks og farmaceutisk sammensætning indeholdende denne
FI924856A (fi) Komplexsalter av hematoporfyrin och dess derivat, samt deras syntes
PT77996A (en) Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
ES8306371A1 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
GR3002155T3 (en) Un-natural ceramide related compounds and preparation thereof
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
DE69105786D1 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
IL63648A0 (en) Azolylalkyl derivatives,their preparation and their use as fungicides
PT90635A (pt) Processo para a preparacao de derivados do acido n-(5,6,7,8-tetra-hidropirido-{2,3-d}pirimidin-6-il-alcanoil)glutamico
HU9601701D0 (en) Aromatic hydroxamic acid compounds, process for producing them and their use
RU92004314A (ru) Комплексные соли гематопорфирина и его производных, способ их производства и фармацевтическое средство
DE69119714D1 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
DE68902887D1 (de) Propargylguanidin-derivate und verfahren zu deren herstellung.
JPS57142957A (en) Ester derivative and anticomplementary agent
JPS5742664A (en) Alpha-substituted ureidophenylacetic acid derivative
EP0496362A3 (en) Process for preparing malonic anhydride for the preparation of 2,2-disubstituted 4,6-dioxo-1,3-dioxanes
JPS56164157A (en) Novel-alpha-oxyphenylacetamide derivative

Legal Events

Date Code Title Description
MM Patent lapsed